DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case–Control Study

BACKGROUND: Accounting for 15–20% of all meningiomas, WHO grade II meningiomas represent an intermediate group regarding risk of tumor recurrence. However, even within this subgroup varying clinical courses are observed with potential occurrence of multiple recurrences. Recently, DNA methylation pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Millesi, Matthias, Ryba, Alice Senta, Hainfellner, Johannes A., Roetzer, Thomas, Berghoff, Anna Sophie, Preusser, Matthias, Heller, Gerwin, Tomasich, Erwin, Sahm, Felix, Roessler, Karl, Wolfsberger, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959647/
https://www.ncbi.nlm.nih.gov/pubmed/35356207
http://dx.doi.org/10.3389/fonc.2022.811729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959647/
https://www.ncbi.nlm.nih.gov/pubmed/35356207
http://dx.doi.org/10.3389/fonc.2022.811729

Ejemplares similares